Plus Therapeutics | CYTX - Operating Expenses

Stock Price
0.30
Daily Change
-0.01 -2.88%
Monthly
15.47%
Yearly
-79.16%
Q1 Forecast
0.29

Plus Therapeutics reported $3.34M in Operating Expenses for its fiscal quarter ending in June of 2023.





Operating Expenses Change Date
Baxter International USD 3.19B 554.4M Dec/2025
Cerus USD 34.78M 2.98M Dec/2024
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Infinity Pharmaceuticals USD 10.7M 1.54M Jun/2023
Northwest Biotherapeutics USD -108.65M 8.26M Sep/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025